Medical Corporation “Ita-no-kai”, Operator of Kurume Chuo Hospital, Files for Bankruptcy with 1.245 Billion Yen in Debt… Performance Decline Due to COVID

News Summary

It has been reported that the medical corporation “Ita-no-kai”, which operated Kurume Chuo Hospital, has filed for bankruptcy with total debts amounting to 1.245 billion yen. The decline in performance due to the impact of the novel coronavirus is cited as the cause. This case highlights key issues in medical M&A and business succession, such as preparing for medical fee revisions, economies of scale, and utilizing tax schemes.

Perspective from M&A Medical Editorial Department

The bankruptcy filing by “Ita-no-kai”, the operator of Kurume Chuo Hospital, suggests how vulnerable the management of medium-sized hospitals supporting regional healthcare can become. The scale of debt exceeding 1.2 billion yen indicates that, rather than just the impact of the COVID-19 pandemic, structural issues predating the pandemic, such as the burden of investment in aging facilities and delays in responding to changing medical needs, are likely behind the situation. In particular, a debt of over 1.2 billion yen implies that independent reconstruction is extremely difficult, making it highly probable that consideration for early M&A or business integration was essential. Strengthening the management base through group affiliation and collaboration with highly specialized medical institutions should be increasingly emphasized to ensure the continuity of regional healthcare.

Issues Highlighted by This News

• The possibility that management issues and facility investment burdens predating the COVID-19 pandemic contributed to the bankruptcy filing.
• The debt scale exceeding 1.2 billion yen suggests a situation where independent reconstruction is difficult.
• Group affiliation and collaboration with specialized medical institutions are essential to ensure the continuity of regional healthcare.
• The importance of adaptability and financial strategy for medium-sized hospitals in the face of change.

Practical Questions Arising from This News

• What measures are other medical institutions experiencing performance deterioration due to the COVID-19 pandemic taking?
• What kind of support are local governments and public institutions providing to protect regional healthcare?
• What M&A schemes should have been considered before reaching the point of filing for bankruptcy?

If You Feel “Should I Consult Too?”

Is your hospital also facing challenges such as no improvement in revenue and expenditure since the COVID-19 pandemic, no prospect for facility upgrades, or a lack of successors? Like “Ita-no-kai”, it is important to consider business succession and M&A options tailored to your hospital’s current situation and future vision before it’s too late. Let’s start by consulting with experts to find the optimal path for your hospital.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a complete success-fee basis as a certified M&A support institution by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultation here